Navigation Links
Accelerate Diagnostics Announces Final Terms of Rights Offering
Date:7/12/2013

TUCSON, Ariz., July 12, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today the final terms of its previously announced $20,000,000 rights offering.  The Company anticipates that the rights offering will commence with the distribution of the final prospectus and related materials to stockholders on or about July 18, 2013.

Under the terms of the rights offering, the Company is distributing, at no charge to the holders of its common stock as of 5:00 p.m., New York City time, on July 8, 2013, which was established as the record date for the rights offering, 0.064038 non-transferable subscription rights for each share of common stock owned on the record date, as more fully described in the prospectus relating to the rights offering.  Each whole subscription right will allow the holder thereof to subscribe to purchase one share of common stock at a subscription price of $8.04 per share.  In addition, any holder of subscription rights exercising his, her or its basic subscription privilege in full will be eligible to subscribe to purchase additional shares of common stock at the same subscription price per share, subject to the conditions and limitations described further in the prospectus.  In the aggregate, the Company intends to issue up to 2,487,562 shares of common stock in connection with the rights offering.

The subscription rights may be exercised until 5:00 p.m. New York City time, on August 7, 2013, as more fully described in the prospectus.  The rights offering period may not be extended.  Any fractional rights remaining after aggregating all of the subscription ri
'/>"/>

SOURCE Accelerate Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
2. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
3. ZyDoc Selects Health Fidelitys REVEAL™ Natural Language Processing (NLP) Platform to Accelerate Time to Value for its MediSapien Web Services
4. Berg Pharma and the Parkinsons Institute ink R&D collaboration to drive disease understanding and accelerate therapeutic and diagnostic development in Parkinsons Disease
5. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
6. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
7. Medical Alarm Provides Investor Update -- Company Surpassing Previous Record Order Levels as Consumer Interest Accelerates
8. Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth
9. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
10. Emerging Pharmaceutical Market in South Africa - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process
11. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 24, 2015 Research ... of the "Future Horizons and Growth Strategies ... Shares and Country Forecasts" report to their ... in the European Blood Banking Market 2015 is ... help current suppliers and potential market entrants identify ...
(Date:7/1/2015)... has acquired West Bend Assisted Living Pharmacy ( ... a proven track record for excellent service to individuals ... involved in their care. Both companies have strong reputations ... to their customers. Genoa ... dedicated to the behavioral health community and those affiliated ...
(Date:7/1/2015)... , July 1, 2015 Egalet ... integrated specialty pharmaceutical company focused on developing, manufacturing ... Bob Radie , president and chief executive ... this summer. He will provide an update on ... (ketorolac tromethamine) Nasal Spray, approved product OXAYDO ...
Breaking Medicine Technology:European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Genoa, a QoL Healthcare Company Acquires West Bend Assisted Living Pharmacy 2Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3
... Feb. 28, 2012  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... will present a company overview at Cowen and Company,s 32nd ... 10:40 a.m. ET at the Boston Marriot Copley Place.   ... be available on the "Investors & Media" section of the ...
... OncoSec Medical Incorporated (OTCBB: ONCS), which is developing ... treat solid tumor cancers, today announced that Investigational Review ... of California San Francisco and the first patient has ... OncoSec,s OMS ElectroImmunotherapy for the treatment of ...
Cached Medicine Technology:OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 2OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 3OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 4
(Date:7/1/2015)... ... 01, 2015 , ... In the United States, summer has always been the ... Saudi Arabia and Dubai, the summer temperatures are so hot, that July vacationers often ... Sam Saleh of ORA Dentistry Spa notes that a trip to the United States, ...
(Date:7/1/2015)... NY (PRWEB) , ... July 01, 2015 , ... For ... DNA is wound, histones, remain constant in the brain, never changing after development in ... discovered that histones are steadily replaced in brain cells throughout life – a process ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... forms, such as organically raised chickens and eggs. Eating organic foods and products ... is cleaner and more environmentally friendly than production chicken farming. Choosing home raised ...
(Date:7/1/2015)... ... July 01, 2015 , ... OncLive® ... Corporation of America (HCA), as it further expands its Strategic Alliance Partnership Program ... With this new partnership, OncLive’s editorial and marketing teams will collaborate with Sarah ...
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, the widow of U.S. ... 15-16th (MSG Keys’ birthday) in memory of her late husband and all of America’s ... of the Bronze Star Medal, died during a Special Forces training exercise in December ...
Breaking Medicine News(10 mins):Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3
... Patricia Hewitt, the health secretary said that computer based ... depression and anxiety//. This will be available to all ... programs- Fear fighter and Beating the blues have been ... However, health experts have warned that computer aided programs ...
... than making you look like one. It steers you towards a ... say researchers. , The report published in the journal ... Dr. David W. Dunstan and team from the International Diabetes Institute, ... who confessed to sedentary lives ruled by lots of TV and ...
... a genomic test may provide detailed information on how ... profiling (GEP) test, known as the Allomap test, is ... rejection instead of routine invasive heart muscle biopsies, but ... levels, the pressure in the heart before pumping, and ...
... that women with a recent diagnosis of cancer in one ... ,This study was conducted by the Chapel Hill ... international research team found that MRI, or magnetic resonance imaging, ... women (3.1 percent) who had recently been diagnosed with cancer ...
... and Company, a leading pharmaceutical manufacturer, has announced ... enzastaurin,// an anti-cancer drug the status of an ... the drug's manufacturer a seven-year right to exclusively ... drugs encourages their development by greatly increasing their ...
... abuse in the US is now being dubbed as a war on ... small part of the growing army of drug addicts, but they tend ... 2006 report by the American Civil Liberties Union, African Americans make up ... those arrested on drug charges. ,They also form 59 ...
Cached Medicine News:Health News:Computer Based Therapy For Depression 2Health News:Sedentary Lives Equal Shorter ‘sweeter’ Liv 2Health News:Gene Test Shown to Measure Heart Function After Transplant 2Health News:MRI Screening of Other Breast Crucial for Patients Diagnosed With Cancer in One Breast 2Health News:African Americans Tend to Suffer More from Drug Abuse 2
PT, PTT, Fibrinogetn & TT Normal and Abnormal Controls...
ApolipoproteinA-1 & B Calibrator...
CRP Calibrator...
Drug controls sera available in three levels for the control of accuracy and percision for up to 18 analytes...
Medicine Products: